Literature DB >> 20335388

Identification of hydroxyxanthones as Na/K-ATPase ligands.

Zhongbing Zhang1, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I Shapiro, Shuyi Si, Zijian Xie.   

Abstract

We have screened a chemical library and identified several novel structures of Na/K-ATPase inhibitors. One group of these inhibitors belongs to polyphenolic xanthone derivatives. Functional characterization reveals the following properties of this group of inhibitors. First, like ouabain, they are potent inhibitors of the purified Na/K-ATPase. Second, their effects on the Na/K-ATPase depend on the number and position of phenolic groups. Methylation of these phenolic groups reduces the inhibitory effect. Third, further characterization of the most potent xanthone derivative, MB7 (3,4,5,6-tetrahydroxyxanthone), reveals that it does not change either Na(+) or ATP affinity of the enzyme. Finally, unlike that of ouabain, the inhibitory effect of MB7 on Na/K-ATPase is not antagonized by K(+). Moreover, MB7 does not activate the receptor Na/K-ATPase/Src complex and fails to stimulate protein kinase cascades in cultured cells. Thus, we have identified a group of novel Na/K-ATPase ligands that can inhibit the pumping function without stimulating the signaling function of Na/K-ATPase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335388      PMCID: PMC2879917          DOI: 10.1124/mol.110.063974

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  43 in total

1.  Identification and characterization of a ouabain-like compound from human plasma.

Authors:  J M Hamlyn; M P Blaustein; S Bova; D W DuCharme; D W Harris; F Mandel; W R Mathews; J H Ludens
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

2.  Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay.

Authors:  Man Liang; Ting Cai; Jiang Tian; Weikai Qu; Zi-Jian Xie
Journal:  J Biol Chem       Date:  2006-05-12       Impact factor: 5.157

Review 3.  Isozymes of the Na+/K+-ATPase.

Authors:  K J Sweadner
Journal:  Biochim Biophys Acta       Date:  1989-05-09

Review 4.  Xanthone derivatives: new insights in biological activities.

Authors:  M M M Pinto; M E Sousa; M S J Nascimento
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

5.  Evidence for the involvement of protein kinase C inhibition by norathyriol in the reduction of phorbol ester-induced neutrophil superoxide anion generation and aggregation.

Authors:  J P Wang; S L Raung; L T Tsao; C N Lin
Journal:  Eur J Pharmacol       Date:  1997-10-01       Impact factor: 4.432

6.  Effects of oligomycin and quercetin on the hydrolytic activities of the (Na+ +K+)-dependent ATPase.

Authors:  J D Robinson; L J Robinson; N J Martin
Journal:  Biochim Biophys Acta       Date:  1984-05-30

7.  Interaction between ouabain and the phosphorylated intermediate of Na,K-ATPase.

Authors:  A Yoda; S Yoda
Journal:  Mol Pharmacol       Date:  1982-11       Impact factor: 4.436

8.  Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m(2) combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer.

Authors:  Mark J McKeage; Martin Reck; Michael B Jameson; Mark A Rosenthal; David Gibbs; Paul N Mainwaring; Lutz Freitag; Richard Sullivan; Joachim Von Pawel
Journal:  Lung Cancer       Date:  2009-05-05       Impact factor: 5.705

9.  Inhibition of (Na+, K+)adenosine triphosphatase and its partial reactions by quercetin.

Authors:  Y Kuriki; E Racker
Journal:  Biochemistry       Date:  1976-11-16       Impact factor: 3.162

10.  Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238.

Authors:  Mara Ferrandi; Isabella Molinari; Paolo Barassi; Elena Minotti; Giuseppe Bianchi; Patrizia Ferrari
Journal:  J Biol Chem       Date:  2004-05-25       Impact factor: 5.157

View more
  8 in total

1.  A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance.

Authors:  James H Matthews; Xiao Liang; Valerie J Paul; Hendrik Luesch
Journal:  ACS Chem Biol       Date:  2018-03-22       Impact factor: 5.100

2.  Disrupted Plasma Membrane Protein Homeostasis in a Xenopus Laevis Model of Retinitis Pigmentosa.

Authors:  Philip Ropelewski; Yoshikazu Imanishi
Journal:  J Neurosci       Date:  2019-05-06       Impact factor: 6.167

Review 3.  Regulation of renal function and structure by the signaling Na/K-ATPase.

Authors:  Jeffrey X Xie; Xin Li; Zijian Xie
Journal:  IUBMB Life       Date:  2013-12-10       Impact factor: 3.885

4.  Cardiac glycoside activities link Na(+)/K(+) ATPase ion-transport to breast cancer cell migration via correlative SAR.

Authors:  Anniefer N Magpusao; George Omolloh; Joshua Johnson; José Gascón; Mark W Peczuh; Gabriel Fenteany
Journal:  ACS Chem Biol       Date:  2014-11-26       Impact factor: 5.100

Review 5.  Protein Interaction and Na/K-ATPase-Mediated Signal Transduction.

Authors:  Xiaoyu Cui; Zijian Xie
Journal:  Molecules       Date:  2017-06-14       Impact factor: 4.411

Review 6.  Na+/K+-ATPase Revisited: On Its Mechanism of Action, Role in Cancer, and Activity Modulation.

Authors:  Jiří Bejček; Vojtěch Spiwok; Eva Kmoníčková; Silvie Rimpelová
Journal:  Molecules       Date:  2021-03-28       Impact factor: 4.411

Review 7.  The Trade-Off between Dietary Salt and Cardiovascular Disease; A Role for Na/K-ATPase Signaling?

Authors:  Joe X Xie; Anna Pearl Shapiro; Joseph Isaac Shapiro
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-17       Impact factor: 5.555

8.  Ouabain and chloroquine trigger senolysis of BRAF-V600E-induced senescent cells by targeting autophagy.

Authors:  Valentin L'Hôte; Régis Courbeyrette; Guillaume Pinna; Jean-Christophe Cintrat; Gwenaëlle Le Pavec; Agnès Delaunay-Moisan; Carl Mann; Jean-Yves Thuret
Journal:  Aging Cell       Date:  2021-08-06       Impact factor: 9.304

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.